national stem-cell therapy logo

Unlocking Burn Healing: Aegle’s Breakthrough Therapy

Aegle Therapeutics logo

Aegle Therapeutics Corp., a clinical-stage biotechnology company, has announced the initiation of its Phase 1/2a clinical trial, marking the dosing of its first patient. The trial will focus on the administration of AGLE-102™, a novel therapy designed to treat severe second-degree burns. AGLE-102™ is an investigational product made up of native extracellular vesicles, which are […]